Article
IGF2 is a Potential Factor in RAI-refractory Non-medullary Thyroid Cancer
2020-10-14
Abstract excerpt
<title>Abstract</title> <p><bold>Background:</bold> Non-medullary thyroid cancer (NMTC) is the most frequent endocrine tumor with in most cases a good prognosis after thyroidectomy and <sup>131</sup>I radioactive iodide (RAI) ablation. In contrast, 30-40% of patients with metastatic NMTC are unresponsive to <sup>131</sup>I RAI treatment as a result of tumor dedifferentiation. Currently, underlying molecular mecha...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 236634c4-8e8f-5581-8ca1-cff902d0b8ff
- DOI
- 10.21203/rs.3.rs-89212/v1